Analyst firms · Morgan Stanley · CABA
Morgan Stanley CABA price target and rating history
Cabaletta Bio Inc. (CABA) · Health Care
Morgan Stanley rates Cabaletta Bio Inc. (CABA) Overweight with a $16 price target, as of its latest action on Jan 27, 2023. It has published 4 rating actions on CABA since October 2021, including 1 upgrade and 1 downgrade.
- Current rating
- Overweight
- Price target
- $16
- Median target, all firms
- Too few
- Actions on CABA
- 4
Morgan Stanley price target on CABA
Every Morgan Stanley rating on CABA
- Jan 27, 2023
- Aug 30, 2022
- Dec 15, 2021
- Oct 19, 2021
Questions about Morgan Stanley and CABA
- What is Morgan Stanley's price target for CABA?
- Morgan Stanley's latest stated price target for Cabaletta Bio Inc. (CABA) is $16, from its action on Jan 27, 2023.
- What is Morgan Stanley's rating on CABA?
- Morgan Stanley rates CABA Overweight, a bullish rating, as of Jan 27, 2023.
- When did Morgan Stanley last change its view on CABA?
- On Jan 27, 2023, Morgan Stanley upgrades to Overweight from Equal-Weight, price target $3 to $16.
All Morgan Stanley ratingsCABA news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.